Sparstolonin B Inhibits Pancreatic Adenocarcinoma through the NF-κB Signaling Pathway

Sparstolonin B significantly decreased Panc-1 and SW1990 cell viability and effectively suppressed the proliferation, migration, and invasion of pancreatic cancer cells as shown by CCK-8, colony formation, and Transwell assays.